Match each pediatric patient presentation with the most appropriate immunization management strategy.
- A 2-month-old infant, born at 27 weeks gestation, who is clinically stable but remains hospitalized in the neonatal intensive care unit.Administer age-appropriate inactivated vaccines; defer rotavirus vaccine while the patient is hospitalized.
- A 12-month-old child presenting for a well-child visit who received high-dose intravenous immunoglobulin (IVIG) for Kawasaki disease at age 2 months.Administer age-appropriate inactivated vaccines; defer measles-mumps-rubella and varicella vaccines for an additional 1 month.
- A 4-year-old child presenting for a well-child visit who completed a 21-day course of daily prednisone (2 mg/kg/day) 5 weeks ago.Administer all age-appropriate vaccines, including live-attenuated vaccines, as the necessary waiting period has elapsed.
- A 2-month-old infant presenting for a well-child visit whose mother received regular infliximab infusions for Crohn's disease throughout the third trimester.Administer age-appropriate inactivated vaccines; rotavirus vaccine is contraindicated due to placental transfer of monoclonal antibodies.
Cevap
The correct matches pair the NICU infant with deferring rotavirus while hospitalized; the Kawasaki patient with a 1-month further delay of MMR/varicella; the post-steroid 4-year-old with receiving all vaccines without delay; and the infliximab-exposed infant with strict contraindication of the rotavirus vaccine.
Each patient scenario requires a specific modification to the routine immunization schedule based on their current clinical environment or recent exposure to immunomodulating therapies. The matching pairs correctly identify these necessary adjustments according to AAP and CDC guidelines.
Adım Adım Çözüm
Anahtar Kavram
Alterations to the routine immunization schedule are required for high-risk populations, including hospitalized preterm infants, patients who received antibody-containing blood products (IVIG), patients recently treated with high-dose corticosteroids, and infants exposed to immunosuppressive biologics in utero.